Cholangiocarcinoma (CCA) is a heterogeneous and often late-diagnosed malignancy in which tissue acquisition, pathological confirmation, and molecular profiling remain clinically challenging. Precision oncology has increased the need for reliable tumour-derived molecular information, particularly when conventional cytology or biopsy is inconclusive or inadequate for next-generation sequencing (NGS). Bile has emerged as a candidate liquid biopsy matrix because it directly drains the biliary tree and may come into contact with malignant or premalignant biliary epithelium, potentially concentrating tumour-derived DNA, RNA, extracellular vesicles (EVs), proteins and metabolites at the site of disease rather than diluting them in the systemic circulation. Bile-derived cell-free DNA (cfDNA) and circulating tumour DNA (ctDNA) are the most mature biomarkers, with matched studies reporting somatic mutation detection in up to 70–71% of bile cfDNA samples compared with 10–54% in plasma, along with higher variant allele fractions and stronger concordance with tumour tissue. The most immediate clinical application is the evaluation of indeterminate biliary strictures, where an NGS-based bile cfDNA assay (Bilemut), evaluated in a mixed cohort of suspicious biliary strictures, achieved an overall sensitivity of 96.4% and a specificity of 69.2%, reaching 100% sensitivity in the 35 patients initially classified as having benign or indeterminate strictures, although this was a single-centre pilot cohort requiring independent validation. DNA methylation, non-coding RNAs, EVs, proteomic and lipidomic signatures are expanding the field beyond mutation detection, with integrated multi-omic approaches showing early promise for diagnosis and risk stratification. Translation to clinical practice remains limited by small cohorts, heterogeneous populations, variable sampling protocols, and the absence of prospective evidence that bile testing changes management or improves outcomes. Its most defensible role is additive rather than substitutive: bile adds molecular information from the local biliary compartment at the moment of an already indicated procedure, in patients in whom tissue is insufficient or non-diagnostic, and plasma is non-informative.
Cholangiocarcinoma (CCA) is a heterogeneous and often late-diagnosed malignancy in which tissue acquisition, pathological confirmation, and molecular profiling remain clinically challenging. Precision oncology has increased the need for reliable tumour-derived molecular information, particularly when conventional cytology or biopsy is inconclusive or inadequate for next-generation sequencing (NGS). Bile has emerged as a candidate liquid biopsy matrix because it directly drains the biliary tree and may come into contact with malignant or premalignant biliary epithelium, potentially concentrating tumour-derived DNA, RNA, extracellular vesicles (EVs), proteins and metabolites at the site of disease rather than diluting them in the systemic circulation. Bile-derived cell-free DNA (cfDNA) and circulating tumour DNA (ctDNA) are the most mature biomarkers, with matched studies reporting somatic mutation detection in up to 70–71% of bile cfDNA samples compared with 10–54% in plasma, along with higher variant allele fractions and stronger concordance with tumour tissue. The most immediate clinical application is the evaluation of indeterminate biliary strictures, where an NGS-based bile cfDNA assay (Bilemut), evaluated in a mixed cohort of suspicious biliary strictures, achieved an overall sensitivity of 96.4% and a specificity of 69.2%, reaching 100% sensitivity in the 35 patients initially classified as having benign or indeterminate strictures, although this was a single-centre pilot cohort requiring independent validation. DNA methylation, non-coding RNAs, EVs, proteomic and lipidomic signatures are expanding the field beyond mutation detection, with integrated multi-omic approaches showing early promise for diagnosis and risk stratification. Translation to clinical practice remains limited by small cohorts, heterogeneous populations, variable sampling protocols, and the absence of prospective evidence that bile testing changes management or improves outcomes. Its most defensible role is additive rather than substitutive: bile adds molecular information from the local biliary compartment at the moment of an already indicated procedure, in patients in whom tissue is insufficient or non-diagnostic, and plasma is non-informative.
Rett syndrome is a severe neurodevelopmental disorder in which motor impairment, apraxia, and limited expressive language can obscure residual cognitive and communicative abilities. This brief report argues that attention and communication in Rett syndrome should be conceptualized not only as impaired domains, but also as partially hidden functions that may become observable through appropriate assessment and rehabilitation methods. Drawing on research on attention, communication training, eye-tracking, telerehabilitation, and transcranial direct current stimulation (tDCS), we propose that technology-assisted approaches are especially relevant because they reduce motor demands and create alternative pathways for interaction. This perspective integrates selected findings from Rett syndrome intervention studies with broader literature on diagnosis, communication, visual attention, and rehabilitation. The resulting framework suggests that child neuropsychological assessment in Rett syndrome should move beyond overt motor-language limitations and prioritize methods capable of detecting attention, intentionality, and responsiveness under supported conditions. Because the supporting evidence is dominated by pilot, single-case, and small-sample studies, the framework is hypothesis-generating and should not be interpreted as evidence that these technologies are uniformly clinically validated.
Rett syndrome is a severe neurodevelopmental disorder in which motor impairment, apraxia, and limited expressive language can obscure residual cognitive and communicative abilities. This brief report argues that attention and communication in Rett syndrome should be conceptualized not only as impaired domains, but also as partially hidden functions that may become observable through appropriate assessment and rehabilitation methods. Drawing on research on attention, communication training, eye-tracking, telerehabilitation, and transcranial direct current stimulation (tDCS), we propose that technology-assisted approaches are especially relevant because they reduce motor demands and create alternative pathways for interaction. This perspective integrates selected findings from Rett syndrome intervention studies with broader literature on diagnosis, communication, visual attention, and rehabilitation. The resulting framework suggests that child neuropsychological assessment in Rett syndrome should move beyond overt motor-language limitations and prioritize methods capable of detecting attention, intentionality, and responsiveness under supported conditions. Because the supporting evidence is dominated by pilot, single-case, and small-sample studies, the framework is hypothesis-generating and should not be interpreted as evidence that these technologies are uniformly clinically validated.
To assess the appropriate empirical antibiotic prescribing and characterize antibiotic de-escalation for suspected bacterial meningitis in children with negative cerebrospinal fluid (CSF) culture at a tertiary teaching hospital in Jordan.
A retrospective study was performed at Jordan University Hospital on children 18 years or younger who were treated with empirical antibiotics for suspected bacterial meningitis and had negative CSF cultures during the study period, from January 2020 to July 2025. Appropriateness of empirical antibiotic therapy was assessed in accordance with the Infectious Diseases Society of America (IDSA) guidelines. Antibiotic de-escalation was evaluated based on modification or discontinuation of the antibiotic regimen within 48–72 hours after the negative culture results.
The study included 208 patients. Vancomycin (91.3%) and ceftriaxone (88.0%) were the most frequently prescribed empirical antibiotics. Overall, 107 patients (51.4%) received an appropriate empirical antibiotic therapy, while 101 (48.6%) did not; of the latter, most received inappropriate therapy due to improper dosing. Successful antibiotic de-escalation was achieved in 122 patients (58.7%), while 56 patients (26.9%) had a missed opportunity for antibiotic de-escalation. Viral meningitis was independently associated with missed antibiotic de-escalation [adjusted odds ratio (AOR) = 2.941, 95% confidence interval (CI): 1.453–5.951; p = 0.003], while children aged 1 month to 18 years had significantly lower odds than neonates (AOR = 0.069, 95% CI: 0.008–0.616; p = 0.017). Missed antibiotic de-escalation was independently associated with longer duration of hospital stay (adjusted B = 0.118, 95% CI: 0.054–0.183; p < 0.001).
More than 50% of patients received a fully guideline-concordant empiric regimen, primarily due to dosage inaccuracies. Over 25% of patients were missed for de-escalation and correlated with extended hospitalization length. Standardization of weight-based dosing and protocolized 48–72 hours antibiotic review can improve antibiotic stewardship.
To assess the appropriate empirical antibiotic prescribing and characterize antibiotic de-escalation for suspected bacterial meningitis in children with negative cerebrospinal fluid (CSF) culture at a tertiary teaching hospital in Jordan.
A retrospective study was performed at Jordan University Hospital on children 18 years or younger who were treated with empirical antibiotics for suspected bacterial meningitis and had negative CSF cultures during the study period, from January 2020 to July 2025. Appropriateness of empirical antibiotic therapy was assessed in accordance with the Infectious Diseases Society of America (IDSA) guidelines. Antibiotic de-escalation was evaluated based on modification or discontinuation of the antibiotic regimen within 48–72 hours after the negative culture results.
The study included 208 patients. Vancomycin (91.3%) and ceftriaxone (88.0%) were the most frequently prescribed empirical antibiotics. Overall, 107 patients (51.4%) received an appropriate empirical antibiotic therapy, while 101 (48.6%) did not; of the latter, most received inappropriate therapy due to improper dosing. Successful antibiotic de-escalation was achieved in 122 patients (58.7%), while 56 patients (26.9%) had a missed opportunity for antibiotic de-escalation. Viral meningitis was independently associated with missed antibiotic de-escalation [adjusted odds ratio (AOR) = 2.941, 95% confidence interval (CI): 1.453–5.951; p = 0.003], while children aged 1 month to 18 years had significantly lower odds than neonates (AOR = 0.069, 95% CI: 0.008–0.616; p = 0.017). Missed antibiotic de-escalation was independently associated with longer duration of hospital stay (adjusted B = 0.118, 95% CI: 0.054–0.183; p < 0.001).
More than 50% of patients received a fully guideline-concordant empiric regimen, primarily due to dosage inaccuracies. Over 25% of patients were missed for de-escalation and correlated with extended hospitalization length. Standardization of weight-based dosing and protocolized 48–72 hours antibiotic review can improve antibiotic stewardship.
This study aimed to investigate the effects of lactic acid fermentation on the antioxidant properties and inhibition of nitric oxide production of extracts prepared from elderberry (Sambucus nigra) slurry.
Elderberry slurry was fermented with Lactobacillus plantarum, and water and 70% ethanol extracts were then prepared from non-fermented and fermented elderberry slurries. Total sugar, reducing sugar, vitamin C, total polyphenol, and flavonoid contents were determined, and antioxidant activities were evaluated using 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging assays, and ferric reducing antioxidant power (FRAP).
Fermentation significantly increased total polyphenol and flavonoid contents compared to non-fermented extracts. Correspondingly, fermented samples exhibited enhanced antioxidant activities, as evidenced by increased DPPH and ABTS radical scavenging activities and FRAP. In addition, fermented extracts showed significantly greater inhibition of nitric oxide production in LPS-stimulated RAW 264.7 macrophages, indicating enhanced inhibition of nitric oxide production.
Fermentation with Lactobacillus plantarum enhanced the bioactive compound content and antioxidant properties of elderberry extracts. These findings suggest that extracts prepared from fermented elderberry slurry may serve as potential functional food-related materials with enhanced antioxidant properties and inhibition of nitric oxide production under in vitro conditions.
This study aimed to investigate the effects of lactic acid fermentation on the antioxidant properties and inhibition of nitric oxide production of extracts prepared from elderberry (Sambucus nigra) slurry.
Elderberry slurry was fermented with Lactobacillus plantarum, and water and 70% ethanol extracts were then prepared from non-fermented and fermented elderberry slurries. Total sugar, reducing sugar, vitamin C, total polyphenol, and flavonoid contents were determined, and antioxidant activities were evaluated using 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging assays, and ferric reducing antioxidant power (FRAP).
Fermentation significantly increased total polyphenol and flavonoid contents compared to non-fermented extracts. Correspondingly, fermented samples exhibited enhanced antioxidant activities, as evidenced by increased DPPH and ABTS radical scavenging activities and FRAP. In addition, fermented extracts showed significantly greater inhibition of nitric oxide production in LPS-stimulated RAW 264.7 macrophages, indicating enhanced inhibition of nitric oxide production.
Fermentation with Lactobacillus plantarum enhanced the bioactive compound content and antioxidant properties of elderberry extracts. These findings suggest that extracts prepared from fermented elderberry slurry may serve as potential functional food-related materials with enhanced antioxidant properties and inhibition of nitric oxide production under in vitro conditions.
The present study investigated clinical and functional changes after a 12-week rehabilitation exercise program in obese and non-obese patients with knee osteoarthritis (KOA).
This retrospective, single-cohort pre–post complete-case analysis without a non-exercise control group included 60 patients with radiographically confirmed KOA (Kellgren-Lawrence grades 1–4). Participants were classified into a non-obese group [body mass index (BMI) < 25 kg/m2, n = 30] and an obese group (BMI ≥ 25 kg/m2, n = 30) according to the Asia-Pacific obesity criteria of the World Health Organization (WHO). All participants completed a standardized 12-week rehabilitation exercise program consisting of flexibility, muscle strengthening, and balance exercises, performed for 60 min per session, three times per week. Clinical and functional outcomes were assessed, including body composition, pain and osteoarthritis index scores, thigh circumference, gluteus medius and isokinetic muscle strength, and functional ability.
A significant group × time interaction was observed for body weight (p = 0.006), whereas no significant interactions were observed for BMI or the other clinical and functional outcomes. Significant main effects of time were observed for BMI, body fat mass (BFM), percent body fat (%BF), pain and osteoarthritis index scores, thigh circumference, gluteus medius and isokinetic muscle strength, and functional ability (all p < 0.05), whereas no significant time effect was observed for skeletal muscle mass.
The 12-week rehabilitation exercise program was associated with improvements in clinical and functional outcomes in both obese and non-obese patients with KOA, with a significant group × time interaction observed only for body weight. Trial registration: KCT0012016; https://cris.nih.go.kr/cris/index/index.do.
The present study investigated clinical and functional changes after a 12-week rehabilitation exercise program in obese and non-obese patients with knee osteoarthritis (KOA).
This retrospective, single-cohort pre–post complete-case analysis without a non-exercise control group included 60 patients with radiographically confirmed KOA (Kellgren-Lawrence grades 1–4). Participants were classified into a non-obese group [body mass index (BMI) < 25 kg/m2, n = 30] and an obese group (BMI ≥ 25 kg/m2, n = 30) according to the Asia-Pacific obesity criteria of the World Health Organization (WHO). All participants completed a standardized 12-week rehabilitation exercise program consisting of flexibility, muscle strengthening, and balance exercises, performed for 60 min per session, three times per week. Clinical and functional outcomes were assessed, including body composition, pain and osteoarthritis index scores, thigh circumference, gluteus medius and isokinetic muscle strength, and functional ability.
A significant group × time interaction was observed for body weight (p = 0.006), whereas no significant interactions were observed for BMI or the other clinical and functional outcomes. Significant main effects of time were observed for BMI, body fat mass (BFM), percent body fat (%BF), pain and osteoarthritis index scores, thigh circumference, gluteus medius and isokinetic muscle strength, and functional ability (all p < 0.05), whereas no significant time effect was observed for skeletal muscle mass.
The 12-week rehabilitation exercise program was associated with improvements in clinical and functional outcomes in both obese and non-obese patients with KOA, with a significant group × time interaction observed only for body weight. Trial registration: KCT0012016; https://cris.nih.go.kr/cris/index/index.do.
Advances in colorectal cancer diagnosis and treatment have led to a growing population of long-term survivors. Many experience persistent physical and psychological sequelae after surgery, radiotherapy, and systemic treatment, affecting not only patients but also partners, adult children, and other close family members, who often assume caregiving roles. This narrative review summarizes current knowledge on the burden experienced by family members of colorectal cancer survivors. It covers the chronic sequelae most relevant to family life, the psychological burden on caregivers, including depression, anxiety, and fear of recurrence, and the relational and dyadic impact on couples. It also addresses the practical, occupational, and financial challenges faced by families, the protective factors that promote resilience, and current intervention strategies and support models. Registry data consistently show that partners of cancer patients have a higher risk of depression, anxiety, and psychiatric hospitalization, a burden that often persists many years after treatment. Emotional distress within couples, fear of recurrence, and difficulties with intimacy and communication are mutually reinforcing. Everyday challenges such as bowel dysfunction, including low anterior resection syndrome, stoma care, and fatigue, add further strain. Couple-based and digital interventions show some benefit, but effects are generally modest. Across healthcare systems, family involvement in survivorship care remains inconsistent. Surgical and cancer care teams have an important opportunity to identify families at risk early, set realistic expectations, and connect them with appropriate psychosocial support.
Advances in colorectal cancer diagnosis and treatment have led to a growing population of long-term survivors. Many experience persistent physical and psychological sequelae after surgery, radiotherapy, and systemic treatment, affecting not only patients but also partners, adult children, and other close family members, who often assume caregiving roles. This narrative review summarizes current knowledge on the burden experienced by family members of colorectal cancer survivors. It covers the chronic sequelae most relevant to family life, the psychological burden on caregivers, including depression, anxiety, and fear of recurrence, and the relational and dyadic impact on couples. It also addresses the practical, occupational, and financial challenges faced by families, the protective factors that promote resilience, and current intervention strategies and support models. Registry data consistently show that partners of cancer patients have a higher risk of depression, anxiety, and psychiatric hospitalization, a burden that often persists many years after treatment. Emotional distress within couples, fear of recurrence, and difficulties with intimacy and communication are mutually reinforcing. Everyday challenges such as bowel dysfunction, including low anterior resection syndrome, stoma care, and fatigue, add further strain. Couple-based and digital interventions show some benefit, but effects are generally modest. Across healthcare systems, family involvement in survivorship care remains inconsistent. Surgical and cancer care teams have an important opportunity to identify families at risk early, set realistic expectations, and connect them with appropriate psychosocial support.
Social engagement is associated with preserved cognition in older adults. We evaluated the predictive value of structural and functional social network characteristics for cognitive resilience among adults aged ≥ 80 years using machine learning models.
We included Framingham Heart Study Offspring participants aged ≥ 80 years and free of dementia at Exam 8 (2005–2008). Eleven social network measures were assessed using the Berkman-Syme Social Network Index. Cognitive resilience was defined as remaining dementia-free through December 2024. Minimum Redundancy Maximum Relevance (mRMR) identified informative features, and principal component analysis (PCA) characterized their multidimensional structure. Logistic regression, classification and regression trees, random forest, XGBoost, and LightGBM were evaluated using five-fold cross-validation. Performance was assessed using area under the receiver operating characteristic curve (AUC), sensitivity, specificity, positive predictive value (PPV), negative predictive value, F1 score, and balanced accuracy. SHapley Additive exPlanations (SHAP) was used to interpret the best-performing model.
The sample of 141 participants consisted of 56.7% females with a median age of 82 years. In total, 107 participants were cognitively resilient. The most frequently selected feature was “Feeling love and affection”. PCA identified one component reflecting overall social connectedness and support (PC1) and another reflecting interaction with friends and social activities (PC2). LightGBM including PC1 and PC2 had the highest discrimination (AUC = 0.694; 95% CI: 0.456–0.897), with PPV = 0.850, F1 = 0.654, and balanced accuracy = 0.616. Within LightGBM, AUC increased from 0.613 to 0.694 after adding PC1 and PC2. SHAP ranked PC1 and PC2 among the four most influential predictors.
Social network characteristics reflecting perceived love, emotional support, family connections, and social interaction may provide incremental predictive information for cognitive resilience. However, overall predictive performance was modest, and larger, more diverse studies incorporating broader biological, behavioral, and clinical factors are needed.
Social engagement is associated with preserved cognition in older adults. We evaluated the predictive value of structural and functional social network characteristics for cognitive resilience among adults aged ≥ 80 years using machine learning models.
We included Framingham Heart Study Offspring participants aged ≥ 80 years and free of dementia at Exam 8 (2005–2008). Eleven social network measures were assessed using the Berkman-Syme Social Network Index. Cognitive resilience was defined as remaining dementia-free through December 2024. Minimum Redundancy Maximum Relevance (mRMR) identified informative features, and principal component analysis (PCA) characterized their multidimensional structure. Logistic regression, classification and regression trees, random forest, XGBoost, and LightGBM were evaluated using five-fold cross-validation. Performance was assessed using area under the receiver operating characteristic curve (AUC), sensitivity, specificity, positive predictive value (PPV), negative predictive value, F1 score, and balanced accuracy. SHapley Additive exPlanations (SHAP) was used to interpret the best-performing model.
The sample of 141 participants consisted of 56.7% females with a median age of 82 years. In total, 107 participants were cognitively resilient. The most frequently selected feature was “Feeling love and affection”. PCA identified one component reflecting overall social connectedness and support (PC1) and another reflecting interaction with friends and social activities (PC2). LightGBM including PC1 and PC2 had the highest discrimination (AUC = 0.694; 95% CI: 0.456–0.897), with PPV = 0.850, F1 = 0.654, and balanced accuracy = 0.616. Within LightGBM, AUC increased from 0.613 to 0.694 after adding PC1 and PC2. SHAP ranked PC1 and PC2 among the four most influential predictors.
Social network characteristics reflecting perceived love, emotional support, family connections, and social interaction may provide incremental predictive information for cognitive resilience. However, overall predictive performance was modest, and larger, more diverse studies incorporating broader biological, behavioral, and clinical factors are needed.
Food is a fundamental human necessity and integral to cultural identity. This study investigates the intention of urban citizens to consume local dairy products in Rasht, Iran. Drawing upon improved planned behavior theory, the study examines the influence of factors such as attitudes towards local dairy products, food heritage, perceptions of food health (good food), willingness to pay, and socio-demographic characteristics on consumer intention.
Data were collected from 220 randomly selected urban citizens of Rasht using a survey questionnaire. Path analysis using partial least squares (PLS) was employed to analyze the data.
The final structural model demonstrated strong explanatory power, accounting for approximately 63% of the variance in attitudes toward local dairy consumption (R2 = 0.631) and approximately 60% of the variance in the intention to consume local dairy products (R2 = 0.598). Path analysis revealed that perceptions of good food (β = 0.512, p < 0.01) and food heritage (β = 0.366, p < 0.01) were the strongest positive predictors of attitudes toward local dairy products. Attitudes toward local and traditional dairy products significantly influenced both willingness to pay (β = 0.682, p < 0.01) and purchase intention (β = 0.387, p < 0.01). Furthermore, willingness to pay exerted a significant direct effect on purchase intention (β = 0.455, p < 0.01), serving as a partial mediator in the relationship between attitude and purchase behavior.
These findings highlight the continued relevance of local dairy products in urban settings and provide valuable insights for local producers and policymakers to promote the consumption of local and sustainable food systems. The strong mediating role of willingness to pay suggests that strategies emphasizing the environmental and cultural value of local dairy may effectively enhance consumer purchase intentions.
Food is a fundamental human necessity and integral to cultural identity. This study investigates the intention of urban citizens to consume local dairy products in Rasht, Iran. Drawing upon improved planned behavior theory, the study examines the influence of factors such as attitudes towards local dairy products, food heritage, perceptions of food health (good food), willingness to pay, and socio-demographic characteristics on consumer intention.
Data were collected from 220 randomly selected urban citizens of Rasht using a survey questionnaire. Path analysis using partial least squares (PLS) was employed to analyze the data.
The final structural model demonstrated strong explanatory power, accounting for approximately 63% of the variance in attitudes toward local dairy consumption (R2 = 0.631) and approximately 60% of the variance in the intention to consume local dairy products (R2 = 0.598). Path analysis revealed that perceptions of good food (β = 0.512, p < 0.01) and food heritage (β = 0.366, p < 0.01) were the strongest positive predictors of attitudes toward local dairy products. Attitudes toward local and traditional dairy products significantly influenced both willingness to pay (β = 0.682, p < 0.01) and purchase intention (β = 0.387, p < 0.01). Furthermore, willingness to pay exerted a significant direct effect on purchase intention (β = 0.455, p < 0.01), serving as a partial mediator in the relationship between attitude and purchase behavior.
These findings highlight the continued relevance of local dairy products in urban settings and provide valuable insights for local producers and policymakers to promote the consumption of local and sustainable food systems. The strong mediating role of willingness to pay suggests that strategies emphasizing the environmental and cultural value of local dairy may effectively enhance consumer purchase intentions.
Gastrointestinal (GI) cancers account for a substantial proportion of global cancer mortality and remain a major focus of translational and clinical oncology. Over the past decade, advances in molecular profiling, biomarker development, and systemic therapies—including liquid biopsy and circulating tumor DNA (ctDNA) for minimal residual disease (MRD) detection and longitudinal monitoring—have substantially enhanced biological resolution. Precision oncology has already produced major clinical successes in selected molecularly defined subsets, although the magnitude and breadth of benefit remain heterogeneous across tumor types and disease settings. Yet, increasing biological precision has not always translated proportionally into predictable and actionable clinical decisions for individual patients. In this critical narrative review, we examine major GI cancers—including colorectal, gastric, esophageal, pancreatic, biliary tract cancers (BTCs), and hepatocellular carcinoma (HCC)—through the lens of conceptual limitations and unmet clinical needs. Across these malignancies, although with important tumor-specific exceptions and different levels of supporting evidence, recurring themes emerge: the gap between precise prognostication and actionable treatments, exemplified by settings in which ctDNA identifies high-risk patients without providing an effective strategy to modify that risk; the limitations of static models applied to dynamic disease processes; and the persistence of empirically driven decision-making despite increasingly detailed molecular information. By framing uncertainty as an intrinsic feature of cancer biology rather than simply a failure of evidence, this review argues for more adaptive clinical frameworks integrating longitudinal molecular, genetic, and clinical information, allowing therapeutic and surveillance strategies to be reassessed as disease evolves rather than relying exclusively on single-time-point characterization. Such frameworks should complement, rather than replace, the established achievements of precision oncology and be tailored to the distinct biological and evidentiary context of each GI cancer type.
Gastrointestinal (GI) cancers account for a substantial proportion of global cancer mortality and remain a major focus of translational and clinical oncology. Over the past decade, advances in molecular profiling, biomarker development, and systemic therapies—including liquid biopsy and circulating tumor DNA (ctDNA) for minimal residual disease (MRD) detection and longitudinal monitoring—have substantially enhanced biological resolution. Precision oncology has already produced major clinical successes in selected molecularly defined subsets, although the magnitude and breadth of benefit remain heterogeneous across tumor types and disease settings. Yet, increasing biological precision has not always translated proportionally into predictable and actionable clinical decisions for individual patients. In this critical narrative review, we examine major GI cancers—including colorectal, gastric, esophageal, pancreatic, biliary tract cancers (BTCs), and hepatocellular carcinoma (HCC)—through the lens of conceptual limitations and unmet clinical needs. Across these malignancies, although with important tumor-specific exceptions and different levels of supporting evidence, recurring themes emerge: the gap between precise prognostication and actionable treatments, exemplified by settings in which ctDNA identifies high-risk patients without providing an effective strategy to modify that risk; the limitations of static models applied to dynamic disease processes; and the persistence of empirically driven decision-making despite increasingly detailed molecular information. By framing uncertainty as an intrinsic feature of cancer biology rather than simply a failure of evidence, this review argues for more adaptive clinical frameworks integrating longitudinal molecular, genetic, and clinical information, allowing therapeutic and surveillance strategies to be reassessed as disease evolves rather than relying exclusively on single-time-point characterization. Such frameworks should complement, rather than replace, the established achievements of precision oncology and be tailored to the distinct biological and evidentiary context of each GI cancer type.
Industrial fruit processing results in massive quantities of by-products, which can pose a risk of environmental pollution. Their utilization can aid in waste management. Although fruit by-products are valuable sources of bioactive compounds for formulating healthy food products, they may have a negative impact on sensory properties. In this study, we aimed to develop healthy cookies with good sensory acceptability by using lemon peel powder (LPP).
The control sample and five samples incorporating LPP (2–10%) were prepared and analysed for proximate composition, physical, colour, and sensory properties, total phenolic content, vitamin C content, and antioxidant capacity.
LPP enhanced the nutritional and functional values of cookies. The cookies incorporated with the LPP had higher levels of ash and crude fibre in comparison with the control cookie. Moreover, they exhibited higher total phenolic content and antioxidant capacity. Vitamin C was detected in LPP-enriched cookies, with levels up to 2.66 mg/100 g. LPP enhanced the spread ratio and sensory scores such as appearance, flavour, and general acceptability.
LPP (4–6%) may be considered as a preferred range for formulating healthy cookies with acceptable sensory properties.
Industrial fruit processing results in massive quantities of by-products, which can pose a risk of environmental pollution. Their utilization can aid in waste management. Although fruit by-products are valuable sources of bioactive compounds for formulating healthy food products, they may have a negative impact on sensory properties. In this study, we aimed to develop healthy cookies with good sensory acceptability by using lemon peel powder (LPP).
The control sample and five samples incorporating LPP (2–10%) were prepared and analysed for proximate composition, physical, colour, and sensory properties, total phenolic content, vitamin C content, and antioxidant capacity.
LPP enhanced the nutritional and functional values of cookies. The cookies incorporated with the LPP had higher levels of ash and crude fibre in comparison with the control cookie. Moreover, they exhibited higher total phenolic content and antioxidant capacity. Vitamin C was detected in LPP-enriched cookies, with levels up to 2.66 mg/100 g. LPP enhanced the spread ratio and sensory scores such as appearance, flavour, and general acceptability.
LPP (4–6%) may be considered as a preferred range for formulating healthy cookies with acceptable sensory properties.
Timely and accurate identification of crop leaf diseases is crucial for food security and sustainable agriculture. This study aims to develop a multi-crop leaf disease recognition framework that covers corn, potato, rice, and tomato, addressing the challenges associated with maintaining high performance under diverse agricultural imaging conditions.
We utilized a balanced dataset of 21,000 curated leaf images spanning fourteen classes, including healthy and diseased samples. A custom convolutional neural network (CNN) was specifically designed to capture fine-grained lesion patterns. The model was trained using a unified pipeline with standardized data splits and preprocessing, ensuring reproducible evaluation. The performance was compared against standard deep learning architectures (ResNet-50, VGG-16) and traditional machine learning classifiers, including k-nearest neighbors (k-NN), support vector machine (SVM), and Random Forest.
The custom CNN achieved near-perfect classification accuracy on the test set, outperforming ResNet-50, VGG-16, and traditional machine learning classifiers under identical conditions. While the model showed potential for generalization to diverse field scenarios, the evaluation was limited to curated datasets. Additionally, the trained model was deployed in a web application to demonstrate real-time inference and practical utility for leaf disease assessment.
This study establishes a robust and reproducible benchmark for multi-crop disease classification. The results highlight the model’s effectiveness in precision agriculture, supporting early intervention strategies, though further validation in field conditions is needed to confirm generalization.
Timely and accurate identification of crop leaf diseases is crucial for food security and sustainable agriculture. This study aims to develop a multi-crop leaf disease recognition framework that covers corn, potato, rice, and tomato, addressing the challenges associated with maintaining high performance under diverse agricultural imaging conditions.
We utilized a balanced dataset of 21,000 curated leaf images spanning fourteen classes, including healthy and diseased samples. A custom convolutional neural network (CNN) was specifically designed to capture fine-grained lesion patterns. The model was trained using a unified pipeline with standardized data splits and preprocessing, ensuring reproducible evaluation. The performance was compared against standard deep learning architectures (ResNet-50, VGG-16) and traditional machine learning classifiers, including k-nearest neighbors (k-NN), support vector machine (SVM), and Random Forest.
The custom CNN achieved near-perfect classification accuracy on the test set, outperforming ResNet-50, VGG-16, and traditional machine learning classifiers under identical conditions. While the model showed potential for generalization to diverse field scenarios, the evaluation was limited to curated datasets. Additionally, the trained model was deployed in a web application to demonstrate real-time inference and practical utility for leaf disease assessment.
This study establishes a robust and reproducible benchmark for multi-crop disease classification. The results highlight the model’s effectiveness in precision agriculture, supporting early intervention strategies, though further validation in field conditions is needed to confirm generalization.
Tumor-immune hybrid cells (THCs) co-expressing leukocyte and epithelial markers arise from cell fusion and may contribute to cancer progression. However, the phenotypic heterogeneity of THCs, their association with macrophage lineage markers, and their clinical significance in breast cancer (BC) remain poorly characterized.
Using multicolor flow cytometry, we analyzed primary breast tumors from 42 patients to characterize THCs expressing pan-leukocyte antigen cluster of differentiation 45 (CD45) together with epithelial markers epithelial cell adhesion molecule (EpCAM) and/or pan-cytokeratin. Expression of macrophage/monocyte-associated markers (CD68, CD163, CD16, CD206) was assessed across THC subpopulations.
THCs were heterogeneous, with CD45+EpCAM+panCK– and CD45+EpCAM+panCK+ subpopulations being most frequent, whereas CD45+EpCAM–panCK+ hybrids were rare. Within EpCAM+ THCs, a substantial proportion expressed M2‑like markers (CD163+, CD206+), indicating an immunosuppressive, pro‑tumor phenotype. The proportion of THCs carrying macrophage markers was increased in larger tumors (T2) and in node‑positive cases (N1–3). Patients with the luminal B [human epidermal growth factor receptor 2 (HER2)–] subtype—characterized by higher proliferative activity—showed a significant enrichment of hybrids expressing CD163 and CD206. Notably, specific rare THC subpopulations were associated with distant metastasis during follow-up: the CD68+CD163+CD16–CD206– phenotype within the CD45+EpCAM–panCK+ fraction and the CD68–CD163–CD16–CD206+ phenotype within the CD45+EpCAM+panCK+ fraction. The former, despite its very low frequency (cutoff 0.65%), showed the highest diagnostic accuracy (95.65%) for predicting poorer survival (p = 0.012).
The predominance of M2-like THCs in more aggressive breast tumors, along with the identification of rare hybrid phenotypes associated with distant metastasis, underscores the clinical significance of these cells. Validation in larger cohorts is warranted to establish their utility as prognostic biomarkers and to elucidate their functional role in BC progression.
Tumor-immune hybrid cells (THCs) co-expressing leukocyte and epithelial markers arise from cell fusion and may contribute to cancer progression. However, the phenotypic heterogeneity of THCs, their association with macrophage lineage markers, and their clinical significance in breast cancer (BC) remain poorly characterized.
Using multicolor flow cytometry, we analyzed primary breast tumors from 42 patients to characterize THCs expressing pan-leukocyte antigen cluster of differentiation 45 (CD45) together with epithelial markers epithelial cell adhesion molecule (EpCAM) and/or pan-cytokeratin. Expression of macrophage/monocyte-associated markers (CD68, CD163, CD16, CD206) was assessed across THC subpopulations.
THCs were heterogeneous, with CD45+EpCAM+panCK– and CD45+EpCAM+panCK+ subpopulations being most frequent, whereas CD45+EpCAM–panCK+ hybrids were rare. Within EpCAM+ THCs, a substantial proportion expressed M2‑like markers (CD163+, CD206+), indicating an immunosuppressive, pro‑tumor phenotype. The proportion of THCs carrying macrophage markers was increased in larger tumors (T2) and in node‑positive cases (N1–3). Patients with the luminal B [human epidermal growth factor receptor 2 (HER2)–] subtype—characterized by higher proliferative activity—showed a significant enrichment of hybrids expressing CD163 and CD206. Notably, specific rare THC subpopulations were associated with distant metastasis during follow-up: the CD68+CD163+CD16–CD206– phenotype within the CD45+EpCAM–panCK+ fraction and the CD68–CD163–CD16–CD206+ phenotype within the CD45+EpCAM+panCK+ fraction. The former, despite its very low frequency (cutoff 0.65%), showed the highest diagnostic accuracy (95.65%) for predicting poorer survival (p = 0.012).
The predominance of M2-like THCs in more aggressive breast tumors, along with the identification of rare hybrid phenotypes associated with distant metastasis, underscores the clinical significance of these cells. Validation in larger cohorts is warranted to establish their utility as prognostic biomarkers and to elucidate their functional role in BC progression.
This study aims to evaluate the antioxidant activities and profile the bioactive compounds of Sinularia sp. collected from the waters of Sabah, Malaysia.
Total phenolic and flavonoid contents, as well as the antioxidant activity [2,2-diphenyl-1-picrylhydrazyl (DPPH); 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS)] of Sinularia sp. methanol extract were evaluated. Additionally, profiling of bioactive compounds was performed using Fourier transform infrared spectroscopy (FTIR), gas chromatography and mass spectrometry (GC-MS), and liquid chromatography-orbitrap-tandem mass spectrometry (LC-orbitrap-MS/MS) approaches.
Sinularia sp. methanol extract contained total phenolic content of 0.053 ± 0.001 mg gallic acid equivalent (GAE)/g and total flavonoid content of 1.78 ± 0.034 mg quercetin equivalents (QE)/g. The antioxidant activities determined by DPPH and ABTS assays showed half-maximal inhibitory concentration (IC50) values of 6.23 ± 0.17 mg/mL and 3.28 ± 0.07 mg/mL, respectively, while the standard ascorbic acid exhibited the highest activity with IC50 values of 0.15 ± 0.01 and 0.08 ± 0.01 mg/mL, respectively. FTIR analysis confirmed functional groups indicative of bioactive compounds, while GC-MS and LC-orbitrap-MS/MS identified 13 and 59 detections, respectively, containing fatty acids, fatty acid esters, alkaloids, steroids, and marine sterols. Interestingly, the key identified antioxidant compounds include vitamin E, docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA).
In conclusion, Sinularia sp. exhibits promising antioxidant potential. Further studies are required to isolate and characterize active compounds for therapeutic applications.
This study aims to evaluate the antioxidant activities and profile the bioactive compounds of Sinularia sp. collected from the waters of Sabah, Malaysia.
Total phenolic and flavonoid contents, as well as the antioxidant activity [2,2-diphenyl-1-picrylhydrazyl (DPPH); 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS)] of Sinularia sp. methanol extract were evaluated. Additionally, profiling of bioactive compounds was performed using Fourier transform infrared spectroscopy (FTIR), gas chromatography and mass spectrometry (GC-MS), and liquid chromatography-orbitrap-tandem mass spectrometry (LC-orbitrap-MS/MS) approaches.
Sinularia sp. methanol extract contained total phenolic content of 0.053 ± 0.001 mg gallic acid equivalent (GAE)/g and total flavonoid content of 1.78 ± 0.034 mg quercetin equivalents (QE)/g. The antioxidant activities determined by DPPH and ABTS assays showed half-maximal inhibitory concentration (IC50) values of 6.23 ± 0.17 mg/mL and 3.28 ± 0.07 mg/mL, respectively, while the standard ascorbic acid exhibited the highest activity with IC50 values of 0.15 ± 0.01 and 0.08 ± 0.01 mg/mL, respectively. FTIR analysis confirmed functional groups indicative of bioactive compounds, while GC-MS and LC-orbitrap-MS/MS identified 13 and 59 detections, respectively, containing fatty acids, fatty acid esters, alkaloids, steroids, and marine sterols. Interestingly, the key identified antioxidant compounds include vitamin E, docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA).
In conclusion, Sinularia sp. exhibits promising antioxidant potential. Further studies are required to isolate and characterize active compounds for therapeutic applications.
Diet-induced oxidative stress and alterations in the intestinal microbial environment are central contributors to obesity-associated metabolic disorders. Functional foods rich in bioactive compounds have emerged as promising dietary interventions to mitigate these disturbances. Cyperus esculentus L. [tiger nut (TN)] is a nutrient-dense tuber rich in dietary fiber, oleic acid, tocopherols, flavonoids, phenolic acids, and phytosterols, which may exert antioxidant, hypolipidemic, and potential prebiotic effects. This study aims to investigate the dose-dependent effects of TN supplementation on oxidative stress, inflammatory status, lipid metabolism, liver histopathology, and selected culture-based gut bacterial indicators in a high-fat diet (HFD)-induced rat model.
Twenty-five male rats were allocated into five groups: a normal control group, an HFD control group, and three HFD groups supplemented with TN powder at 10%, 20%, or 30% (w/w). Biochemical markers of oxidative stress, lipid profile, and inflammation were evaluated, and liver histopathology was examined. Gut bacterial assessment was performed using culture-based isolation and phenotypic identification of selected bacterial groups.
TN supplementation significantly increased anti-oxidant enzymes, reduced lipid peroxidation, improved serum lipid profile, and decreased inflammatory markers compared with the control group, with the greatest improvements observed in the 20% TN group. Histopathological examination demonstrated marked attenuation of HFD-induced hepatic injury, with the 20% TN group exhibiting near-normal hepatic architecture. Culture-based microbial assessment suggested that TN supplementation may favorably influence selected intestinal bacterial indicators.
TN supplementation, particularly at the 20% inclusion level, effectively ameliorated HFD-induced oxidative stress, dyslipidemia, inflammation, and hepatic injury. Culture-based findings suggest that TN supplementation may favorably influence selected intestinal bacterial indicators. However, confirmation using sequencing-based microbiome approaches is required before definitive conclusions regarding prebiotic effects or gut microbiota modulation can be drawn.
Diet-induced oxidative stress and alterations in the intestinal microbial environment are central contributors to obesity-associated metabolic disorders. Functional foods rich in bioactive compounds have emerged as promising dietary interventions to mitigate these disturbances. Cyperus esculentus L. [tiger nut (TN)] is a nutrient-dense tuber rich in dietary fiber, oleic acid, tocopherols, flavonoids, phenolic acids, and phytosterols, which may exert antioxidant, hypolipidemic, and potential prebiotic effects. This study aims to investigate the dose-dependent effects of TN supplementation on oxidative stress, inflammatory status, lipid metabolism, liver histopathology, and selected culture-based gut bacterial indicators in a high-fat diet (HFD)-induced rat model.
Twenty-five male rats were allocated into five groups: a normal control group, an HFD control group, and three HFD groups supplemented with TN powder at 10%, 20%, or 30% (w/w). Biochemical markers of oxidative stress, lipid profile, and inflammation were evaluated, and liver histopathology was examined. Gut bacterial assessment was performed using culture-based isolation and phenotypic identification of selected bacterial groups.
TN supplementation significantly increased anti-oxidant enzymes, reduced lipid peroxidation, improved serum lipid profile, and decreased inflammatory markers compared with the control group, with the greatest improvements observed in the 20% TN group. Histopathological examination demonstrated marked attenuation of HFD-induced hepatic injury, with the 20% TN group exhibiting near-normal hepatic architecture. Culture-based microbial assessment suggested that TN supplementation may favorably influence selected intestinal bacterial indicators.
TN supplementation, particularly at the 20% inclusion level, effectively ameliorated HFD-induced oxidative stress, dyslipidemia, inflammation, and hepatic injury. Culture-based findings suggest that TN supplementation may favorably influence selected intestinal bacterial indicators. However, confirmation using sequencing-based microbiome approaches is required before definitive conclusions regarding prebiotic effects or gut microbiota modulation can be drawn.
Micro- and nanoplastics (MNPs) have emerged as ubiquitous environmental pollutants, infiltrating terrestrial, aquatic, and atmospheric ecosystems. Recent research highlights a critical, bidirectional relationship between these particles and microbiota, particularly within the gastrointestinal (GI) tract of humans and animals. The gut microbiota, a complex and diverse community of trillions of microbes residing in the human GI tract, plays a critical role in host digestion, metabolism, immune function, and overall health. Disruption of this microbial ecosystem, known as dysbiosis, has been linked to a wide range of diseases. MNP-induced gut dysbiosis also involves complex molecular mechanisms requiring integrative approaches. Multi-omics technologies are essential to identify pathways affected by exposure, including immune responses, oxidative stress, and host-microbe interactions. However, their use in human studies remains limited. Large-scale longitudinal studies combined with multi-omics analyses are crucial to clarify systemic health implications of microplastic exposure and develop mitigation strategies.
Micro- and nanoplastics (MNPs) have emerged as ubiquitous environmental pollutants, infiltrating terrestrial, aquatic, and atmospheric ecosystems. Recent research highlights a critical, bidirectional relationship between these particles and microbiota, particularly within the gastrointestinal (GI) tract of humans and animals. The gut microbiota, a complex and diverse community of trillions of microbes residing in the human GI tract, plays a critical role in host digestion, metabolism, immune function, and overall health. Disruption of this microbial ecosystem, known as dysbiosis, has been linked to a wide range of diseases. MNP-induced gut dysbiosis also involves complex molecular mechanisms requiring integrative approaches. Multi-omics technologies are essential to identify pathways affected by exposure, including immune responses, oxidative stress, and host-microbe interactions. However, their use in human studies remains limited. Large-scale longitudinal studies combined with multi-omics analyses are crucial to clarify systemic health implications of microplastic exposure and develop mitigation strategies.
This Letter examines evidence that ganoderic acid DM (GA-DM) is associated with caspase activation, changes in autophagy markers, and increased human leukocyte antigen (HLA) class II-restricted interleukin-2 (IL-2) release in a peptide-specific T-cell hybridoma assay using engineered diffuse large B-cell lymphoma (DLBCL) models, and outlines the viability-controlled tissue and ex vivo studies needed to assess autophagic flux and clinical relevance.
This Letter examines evidence that ganoderic acid DM (GA-DM) is associated with caspase activation, changes in autophagy markers, and increased human leukocyte antigen (HLA) class II-restricted interleukin-2 (IL-2) release in a peptide-specific T-cell hybridoma assay using engineered diffuse large B-cell lymphoma (DLBCL) models, and outlines the viability-controlled tissue and ex vivo studies needed to assess autophagic flux and clinical relevance.
Cardio-oncology has emerged as a critical interdisciplinary field addressing the growing burden of cardiovascular complications arising from modern cancer therapies. While advances in chemotherapy, targeted agents, and immunotherapies have substantially improved cancer survival, they have concurrently led to a significant rise in cancer therapy-related cardiac dysfunction (CTRCD), contributing to increased long-term morbidity and mortality among cancer survivors. Conventional surveillance strategies often detect cardiotoxicity only after irreversible myocardial injury has occurred, accentuating the need for more precise, proactive, and personalized approaches. Theranostics, integrating diagnostic imaging, molecular biomarkers, and targeted therapeutics, offers a promising paradigm to enable early detection, risk stratification, and tailored cardioprotective interventions in cardio-oncology. This review synthesizes recent advances in theranostic strategies relevant to cardio-oncology, spanning imaging-based, biomarker-driven, and nanotechnology-enabled approaches. Advanced imaging modalities such as hybrid PET/MRI, AI-enhanced echocardiography, and novel molecular radiotracers [e.g., 68Ga-FAPI, 18F-DHMT, [68Ga]pentixafor] enable early identification of subclinical myocardial injury, inflammation, fibrosis, and metabolic dysfunction before overt declines in left ventricular ejection fraction occur. Complementing imaging, biomarker-driven theranostics including high-sensitivity cardiac troponins, natriuretic peptides, circulating and exosomal microRNAs, and cardiomyocyte-specific cell-free DNA, provide minimally invasive, real-time insights into myocardial stress, injury, and immune-mediated cardiotoxicity. Nanotheranostic platforms, such as liposomal doxorubicin and immunomodulatory nanoparticles, further enhance therapeutic precision by reducing off-target cardiac exposure while preserving antitumor efficacy. Despite these advances, clinical translation remains hindered by interdisciplinary fragmentation, limited access to advanced infrastructure, high development costs, regulatory heterogeneity between agencies, and reliance on surrogate endpoints rather than long-term cardiovascular outcomes. Theranostics represents a transformative approach in cardio-oncology. Integration of advanced imaging, molecular biomarkers, artificial intelligence, and nanotechnology holds significant promise for preserving cardiac health without compromising oncologic success. Embedding theranostic strategies into routine cardio-oncology practice is essential to advancing precision medicine and improving cardiovascular outcomes for cancer patients worldwide.
Cardio-oncology has emerged as a critical interdisciplinary field addressing the growing burden of cardiovascular complications arising from modern cancer therapies. While advances in chemotherapy, targeted agents, and immunotherapies have substantially improved cancer survival, they have concurrently led to a significant rise in cancer therapy-related cardiac dysfunction (CTRCD), contributing to increased long-term morbidity and mortality among cancer survivors. Conventional surveillance strategies often detect cardiotoxicity only after irreversible myocardial injury has occurred, accentuating the need for more precise, proactive, and personalized approaches. Theranostics, integrating diagnostic imaging, molecular biomarkers, and targeted therapeutics, offers a promising paradigm to enable early detection, risk stratification, and tailored cardioprotective interventions in cardio-oncology. This review synthesizes recent advances in theranostic strategies relevant to cardio-oncology, spanning imaging-based, biomarker-driven, and nanotechnology-enabled approaches. Advanced imaging modalities such as hybrid PET/MRI, AI-enhanced echocardiography, and novel molecular radiotracers [e.g., 68Ga-FAPI, 18F-DHMT, [68Ga]pentixafor] enable early identification of subclinical myocardial injury, inflammation, fibrosis, and metabolic dysfunction before overt declines in left ventricular ejection fraction occur. Complementing imaging, biomarker-driven theranostics including high-sensitivity cardiac troponins, natriuretic peptides, circulating and exosomal microRNAs, and cardiomyocyte-specific cell-free DNA, provide minimally invasive, real-time insights into myocardial stress, injury, and immune-mediated cardiotoxicity. Nanotheranostic platforms, such as liposomal doxorubicin and immunomodulatory nanoparticles, further enhance therapeutic precision by reducing off-target cardiac exposure while preserving antitumor efficacy. Despite these advances, clinical translation remains hindered by interdisciplinary fragmentation, limited access to advanced infrastructure, high development costs, regulatory heterogeneity between agencies, and reliance on surrogate endpoints rather than long-term cardiovascular outcomes. Theranostics represents a transformative approach in cardio-oncology. Integration of advanced imaging, molecular biomarkers, artificial intelligence, and nanotechnology holds significant promise for preserving cardiac health without compromising oncologic success. Embedding theranostic strategies into routine cardio-oncology practice is essential to advancing precision medicine and improving cardiovascular outcomes for cancer patients worldwide.
Novel approaches are needed to expand access to non-pharmacological pain management options. This study’s objective was to test and evaluate the acceptability, feasibility, and treatment effects of videoconference-based pain consultations among adults prescribed opioids for chronic pain.
A one-group pre-post pilot feasibility design was used to recruit adults with a chronic pain diagnosis. Convenience sampling was restricted to United States (U.S.) residents in Washington State. Three videoconference-based 45-minute sessions were offered from participants’ choice of two non-pharmacological modalities delivered by yoga, massage, chiropractic, and physical therapists. Six sessions were offered in total per participant (once weekly for six weeks). Pain intensity/interference, depression, anxiety, pain self-efficacy, thwarted belongingness, spiritual well-being, and opioid misuse were assessed at baseline and post-intervention using online surveys to determine whether improvements could be detected. Data were also captured on recruitment and retention as a measure of feasibility, while session attendance and satisfaction surveys measured acceptability.
Sixteen participants completed 92 treatment modality sessions. Yoga therapy was the most selected option (n = 11), followed by physical therapy (n = 9), massage therapy (n = 8), and chiropractic therapy (n = 4). Attendance was 95% at the scheduled sessions. Significant improvements from baseline to week six were found in pain intensity and interference, depressive symptoms, and thwarted belongingness.
Multidisciplinary virtual pain consultations delivered via videoconferencing technology served as a feasible option to access complementary and integrative therapies. Improvements were detected in pain-related and psychosocial outcomes. Structured virtual approaches may represent a scalable strategy to expand non-pharmacologic treatment options for adults with chronic pain. Protocol for this study was registered a priori through Clinical Trials Network (#NCT05098158).
Novel approaches are needed to expand access to non-pharmacological pain management options. This study’s objective was to test and evaluate the acceptability, feasibility, and treatment effects of videoconference-based pain consultations among adults prescribed opioids for chronic pain.
A one-group pre-post pilot feasibility design was used to recruit adults with a chronic pain diagnosis. Convenience sampling was restricted to United States (U.S.) residents in Washington State. Three videoconference-based 45-minute sessions were offered from participants’ choice of two non-pharmacological modalities delivered by yoga, massage, chiropractic, and physical therapists. Six sessions were offered in total per participant (once weekly for six weeks). Pain intensity/interference, depression, anxiety, pain self-efficacy, thwarted belongingness, spiritual well-being, and opioid misuse were assessed at baseline and post-intervention using online surveys to determine whether improvements could be detected. Data were also captured on recruitment and retention as a measure of feasibility, while session attendance and satisfaction surveys measured acceptability.
Sixteen participants completed 92 treatment modality sessions. Yoga therapy was the most selected option (n = 11), followed by physical therapy (n = 9), massage therapy (n = 8), and chiropractic therapy (n = 4). Attendance was 95% at the scheduled sessions. Significant improvements from baseline to week six were found in pain intensity and interference, depressive symptoms, and thwarted belongingness.
Multidisciplinary virtual pain consultations delivered via videoconferencing technology served as a feasible option to access complementary and integrative therapies. Improvements were detected in pain-related and psychosocial outcomes. Structured virtual approaches may represent a scalable strategy to expand non-pharmacologic treatment options for adults with chronic pain. Protocol for this study was registered a priori through Clinical Trials Network (#NCT05098158).
Dopamine presents a striking postsynaptic paradox: it is stored in synaptic vesicles and released in quantal events, yet every established mammalian dopamine receptor (D1–D5) is a GPCR. Whether—and by what mechanism—dopamine can generate rapid postsynaptic ion flow in the mammalian brain therefore remains unresolved. This Perspective shifts attention from release to the receiving cell and reassesses evidence for fast dopamine-evoked changes in membrane conductance. Although quantal dopamine release can generate relatively rapid D2R–GIRK-mediated postsynaptic currents, this indirect metabotropic mechanism may not account for all reported rapid dopamine-dependent changes in membrane conductance. Electrophysiological studies show millisecond-scale dopaminergic responses and direct dopamine-gated channels in invertebrates, whereas a vertebrate-derived hybrid cell line and chick neurons display rapid dopamine-dependent conductance changes or ion-channel regulation. These findings do not identify a mammalian ionotropic dopamine receptor, but they establish electrophysiological phenomena that remain mechanistically unexplained. A recent preprint presents evidence that the delta-type glutamate receptors GluD1 and GluD2 (previously known as delta1 and delta2 glutamate receptors) may act as dopamine-responsive ion channels tuned by G-protein subunits. Independent studies must now determine whether physiological dopamine concentrations evoke rapid GluD currents in native neurons and whether these currents influence defined dopaminergic circuits in vivo. Other experimentally tractable hypotheses include an unconventional dopamine-gated channel, direct coupling between a dopamine GPCR and an ion channel, and receptor homomers or heteromers with emergent ion-handling properties. Molecular-dynamics simulations showing spontaneous Na+ entry deep into D2R support intrareceptor ion access, but not complete transmembrane permeation. By separating established observations, recent preprint data, and mechanistic speculation, this Perspective defines a testable framework for identifying how dopamine binding is converted into postsynaptic ion flow and for determining whether dopamine can support fast neurotransmission in mammals.
Dopamine presents a striking postsynaptic paradox: it is stored in synaptic vesicles and released in quantal events, yet every established mammalian dopamine receptor (D1–D5) is a GPCR. Whether—and by what mechanism—dopamine can generate rapid postsynaptic ion flow in the mammalian brain therefore remains unresolved. This Perspective shifts attention from release to the receiving cell and reassesses evidence for fast dopamine-evoked changes in membrane conductance. Although quantal dopamine release can generate relatively rapid D2R–GIRK-mediated postsynaptic currents, this indirect metabotropic mechanism may not account for all reported rapid dopamine-dependent changes in membrane conductance. Electrophysiological studies show millisecond-scale dopaminergic responses and direct dopamine-gated channels in invertebrates, whereas a vertebrate-derived hybrid cell line and chick neurons display rapid dopamine-dependent conductance changes or ion-channel regulation. These findings do not identify a mammalian ionotropic dopamine receptor, but they establish electrophysiological phenomena that remain mechanistically unexplained. A recent preprint presents evidence that the delta-type glutamate receptors GluD1 and GluD2 (previously known as delta1 and delta2 glutamate receptors) may act as dopamine-responsive ion channels tuned by G-protein subunits. Independent studies must now determine whether physiological dopamine concentrations evoke rapid GluD currents in native neurons and whether these currents influence defined dopaminergic circuits in vivo. Other experimentally tractable hypotheses include an unconventional dopamine-gated channel, direct coupling between a dopamine GPCR and an ion channel, and receptor homomers or heteromers with emergent ion-handling properties. Molecular-dynamics simulations showing spontaneous Na+ entry deep into D2R support intrareceptor ion access, but not complete transmembrane permeation. By separating established observations, recent preprint data, and mechanistic speculation, this Perspective defines a testable framework for identifying how dopamine binding is converted into postsynaptic ion flow and for determining whether dopamine can support fast neurotransmission in mammals.
Previous